市場調查報告書
商品編碼
1541054
2024-2032 年按產品、應用、技術(延時顯微鏡、光漂白後的螢光恢復、螢光共振能量轉移、高內涵篩選等)和地區分類的活細胞成像市場報告Live Cell Imaging Market Report by Product, Application, Technology (Time-Lapse Microscopy, Fluorescence Recovery after Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening, and Others), and Region 2024-2032 |
2023年全球活細胞成像IMARC Group規模達23億美元。由於研究蛋白質的操作效率而導致的需求不斷上升、開發新藥的醫學研究不斷創新以及由於採用久坐的生活方式而導致的各種慢性病的患病率不斷上升,這些都是推動市場的一些關鍵因素。
活細胞成像是指檢查生長培養基中隨時間變化的動態活細胞。它包含在顯微鏡載物台上培養細胞的詳細方案和技術,並保持恆定的焦平面以即時追蹤細胞過程。它依靠相差顯微鏡和明場來照亮細胞培養物並檢查各種細胞器,例如質體、粒線體、中心體、內質網和核醣體。它受到成像方式、介質、溫度、濕度、pH、滲透壓和光子劑量的影響,這些對於維持細胞健康至關重要。活細胞成像還可以監測細胞融合事件,透過使用光漂白後螢光恢復 (FRAP) 確定分子的遷移率,並測量各種修改,例如一段時間內凝結物的生長或老化。它透過端點檢測中經常錯過的瞬態事件的可視化提供重要的細胞資料,並揭示最佳時間點。它通常用於檢查受精過程、細胞發育、細胞訊號傳導過程和細胞分化。此外,由於活細胞成像可提供有關細胞培養物的準確資訊,因此被世界各地的生物學家、藥理學家和毒理學家所利用。
目前,由於活細胞成像在研究蛋白質和各種分子相互作用方面的操作效率,對活細胞成像的需求不斷增加,這是對市場產生積極影響的主要因素之一。除此之外,醫學研究領域的創新數量不斷增加,以開發新的藥物和療法來治療個人的各種危及生命的疾病。再加上久坐的生活方式導致各種慢性病的盛行率不斷上升,這提供了良好的市場前景。此外,擴大利用高內涵篩選(HCS)來提高藥物開發過程的時間和成本效益,並降低毒性,正在推動市場的成長。除此之外,各國管理機構為改善醫療基礎設施和開發先進的外科手術以為患者提供有效治療而進行的投資不斷增加,也促進了市場的成長。此外,研究實驗室擴大使用活細胞成像來維持細胞活力,這也促進了市場的成長。此外,主要市場參與者正在開發活細胞成像技術,在相機技術、靈敏度和像素密度方面具有各種增強功能。
The global live cell imaging market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032. The escalating demand due to its operational efficiency in studying proteins, rising innovations made in medical research to develop novel drugs, and the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles represent some of the key factors driving the market.
Live cell imaging refers to the examination of dynamic living cells in their growth medium that change over time. It comprises detailed protocols and techniques to culture cells on the microscope stage and maintains a constant focal plane to follow cellular processes in real time. It relies on phase contrast microscopy and brightfield to illuminate the cell culture and examine various cell organelles, such as plastids, mitochondria, centrosomes, endoplasmic reticulum, and ribosomes. It is influenced by imaging modality, media, temperature, humidity, pH, osmolarity, and photon dose, which are essential for maintaining cellular health. Live cell imaging also allows monitoring of cell fusion events, determining the mobility of molecules by using fluorescence recovery after photobleaching (FRAP) and measuring various modifications, such as growth or aging of condensate over a period. It provides essential cellular data through the visualization of transient events that are often missed in endpoint assays and revealing optimal time points. It is often utilized to examine the fertilization process, cellular development, cell signaling process, and cell differentiation. Furthermore, as live cell imaging provides accurate information on cell cultures, it is utilized by biologists, pharmacologists, and toxicologists around the world.
At present, the escalating demand for live cell imaging due to its operational efficiency in studying proteins and a wide variety of molecular interactions represents one of the primary factors influencing the market positively. Besides this, there is a rise in the number of innovations made in medical research to develop novel drugs and therapies to treat various life-threatening conditions in individuals. This, coupled with the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles, is offering a favorable market outlook. In addition, the increasing utilization of high-content screening (HCS) to make drug development processes time and cost-efficient and reduce toxicity is propelling the growth of the market. Apart from this, the rising number of investments made by governing agencies of various countries to improve healthcare infrastructure and develop advanced surgical procedures to provide effective treatment to patients is contributing to the growth of the market. Additionally, the increasing employment of live cell imaging in research laboratories to maintain cell viability is bolstering the market growth. Furthermore, key market players are developing live cell imaging techniques with various enhanced features in camera technology, sensitivity, and pixel density.
IMARC Group provides an analysis of the key trends in each sub-segment of the global live cell imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and technology.
Equipment
Consumable
Software
The report has provided a detailed breakup and analysis of the live cell imaging market based on the product. This includes equipment, consumable, and software. According to the report, equipment represented the largest segment.
Cell Biology
Developmental Biology
Stem Cell and Drug Discovery
Others
A detailed breakup and analysis of the live cell imaging market based on the application has also been provided in the report. This includes cell biology, developmental biology, stem cell and drug discovery, and others. According to the report, cell biology accounted for the largest market share.
Time-Lapse Microscopy
Fluorescence Recovery after Photobleaching (FRAP)
Fluorescence Resonance Energy Transfer (FRET)
High Content Screening (HCS)
Others
A detailed breakup and analysis of the live cell imaging market based on the technology has also been provided in the report. This includes time lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), and others. According to the report, fluorescence recovery after photobleaching (FRAP) accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for live cell imaging. Some of the factors driving the North America live cell imaging market included rising investments made by governing agencies, increasing occurrence of cancer among the masses, the growing initiatives in drug discovery, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global live cell imaging market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have also been provided. Some of the companies covered include Becton Dickinson and Company (BD), Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.